Home » Topics » Cancer, BioWorld Science

Cancer, BioWorld Science
RSS

NuChem anticancer agent inhibits human melanoma metastasis in mice

Feb. 9, 2000

Novogen initiates phase I clinical trial with potential prostate cancer treatment

Feb. 9, 2000

Lorus Therapeutics receives US patent for antisense cancer therapies

Feb. 9, 2000

U.S. patent issued for B-cell lymphoma therapy

Feb. 9, 2000

Porphyrins designed at Schering for PDT and MRI

Feb. 9, 2000

Chinese investigators design novel antitumor agents

Feb. 8, 2000

Roche announces limitations on availability of FUDR

Feb. 8, 2000

Magainin begins phase II trial of squalamine in ovarian cancer

Feb. 8, 2000

Aptosyn/Xeloda combination to be tested in breast and colorectal cancers

Feb. 8, 2000

Peloruside A: a cytotoxic macrolide isolated from a marine sponge in New Zealand

Feb. 7, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 2, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...
5-HT2R allosteric ligands attenuate cocaine use and seeking behavior
BioWorld Science
Serotonergic G-protein-coupled receptors (GPCRs), including the 5-HT2A receptor (5-HT2AR) and 5-HT2CR, are key regulators of cortical signaling pathways and...